Source: Annual Congress 2012 - Pulmonary circulation: clinical aspects of PAH and associated PH
Disease area: Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
I. Mascher, H. Tiede, C. Tanislav, R. Voswinckel, H. A. Ghofrani, W. Seeger, F. Reichenberger (Giessen, Gauting, Germany). Relevance of persistent foramen ovale in PAH patients on pulmonary vasoactive treatment. Eur Respir J 2012; 40: Suppl. 56, 924

Member's Comments

No comment yet.

Related content which might interest you: The prevalence of patent foramen ovale in chronic obstructive pulmonary disease patients with increased pulmonary hypertension Source: Annual Congress 2009 - Pulmonary vascular diseases Year: 2009 Unusual treatment of patent foramen ovale after pneumonectomy Source: Eur Respir J 2010; 35: 929-931 Year: 2010 Impact of a patent foramen ovale (PFO) presence in patients with GOLD stage II chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2012 - Pathophysiological mechanisms in disease: new insights Year: 2012 Patent foramen ovale causing position-dependent shunting in a patient, when laying down her corset Source: Eur Respir J 2001; 18: 731-733 Year: 2001 The influence of patent foramen ovale on oxygen desaturation in obstructive sleep apnoea Source: Eur Respir J 2007; 29: 149-155 Year: 2007 Unusual presentation for a patent ductus arteriosus Source: Eur Respir Rev 2009; 18: 174-176 Year: 2009 Pulmonary vein stenosis after pulmonary vein isolation for atrial fibrillation: diagnosis and treatment Source: International Congress 2017 – Open questions in pulmonary vascular diseases Year: 2017 Interventricular septum function in patients with COPD complicated by pulmonary artery hypertension Source: Annual Congress 2009 - Imaging of COPD, asthma and emphysema in evolution Year: 2009 Intracardiac shunt measurement by MRI in patients with pulmonary arterial hypertension caused by a congenital septum defect Source: Eur Respir J 2005; 26: Suppl. 49, 560s Year: 2005 Prognostic value of right ventricular dilatation in patients with low-risk pulmonary embolism Source: Eur Respir J, 50 (6) 1701611; 10.1183/13993003.01611-2017 Year: 2017 Impact of residual pulmonary obstruction on the long-term outcome of patients with pulmonary embolism Source: Eur Respir J, 49 (5) 1601980; 10.1183/13993003.01980-2016 Year: 2017 Prediction of right ventricular dysfunction in patients with pulmonary embolism Source: Eur Respir J 2007; 30: Suppl. 51, 602s Year: 2007 Right-to-left shunt in pulmonary hypertension Source: Eur Respir J 2007; 30: Suppl. 51, 344s Year: 2007 Effect of atrial septostomy on the survival of patients with severe pulmonary arterial hypertension Source: Eur Respir J 2011; 38: 1343-1348 Year: 2011 Evaluation of right atrium remodeling in patients with COPD complicated by pulmonary artery hypertension Source: Annual Congress 2010 - State of the art imaging Year: 2010 Non-invasive monitoring of intrapulmonary shunt in patients with pulmonary hypertension Source: Annual Congress 2010 - Pulmonary circulation I Year: 2010 Prognostic value of right ventricular dilatation in patients with low risk pulmonary embolism Source: International Congress 2017 – Prognostic factors and outcomes in pulmonary embolism Year: 2017 Therapeutic approaches in adults with congenital heart disease-associated pulmonary arterial hypertension Source: Eur Respir Rev 2010 19: 300-307 Year: 2010 Long-term hemodynamic benefits after ‘treat-to-close’ for intracardiac shunts and pulmonary hypertension Source: Virtual Congress 2020 – Right ventricular function and pulmonary hypertension Year: 2020 Anomalous pulmonary venous drainage (APVD) in patients with suspected pulmonary hypertension (PH) Source: International Congress 2018 – Clinical aspects of pulmonary hypertension Year: 2018